Targeting CAM-DR and Mitochondrial Transfer for the Treatment of Multiple Myeloma

The prognosis of patients with multiple myeloma (MM) has improved dramatically with the introduction of new therapeutic drugs, but the disease eventually becomes drug-resistant, following an intractable and incurable course. A myeloma niche (MM niche) develops in the bone marrow microenvironment and...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Rikio, Ogiya, Daisuke, Ogawa, Yoshiaki, Kawada, Hiroshi, Ando, Kiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689110/
https://www.ncbi.nlm.nih.gov/pubmed/36354732
http://dx.doi.org/10.3390/curroncol29110672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689110/
https://www.ncbi.nlm.nih.gov/pubmed/36354732
http://dx.doi.org/10.3390/curroncol29110672

Ejemplares similares